Sponsor:
UCLA
Code:
NCT07346170
Conditions
Spine Metastasis
Stereotactic Body Radiation Therapy (SBRT)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Stereotactic Body Radiation Therapy (SBRT)
Computed Tomography (CT) Simulation
Magnetic Resonance Imaging (MRI)
Questionnaires
Brief summary:
Conditions
Spine Metastasis
Stereotactic Body Radiation Therapy (SBRT)
Study ID
NCT07346170
Start date
Nov 5, 2026
Status verified date
Nov, 2026
Completion date
Nov 30, 2029
Anticipated
Primary completion date
May 31, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
50 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Treatment - Decompression Surgery
experimental: Treatment - Debulking Surgery
Interventions
Stereotactic Body Radiation Therapy (SBRT)
Computed Tomography (CT) Simulation
Magnetic Resonance Imaging (MRI)
Questionnaires
Primary outcome measure
Central contacts
Locations
University of California, San Francisco
Recruiting
San Francisco, California, United States, 94143
Contacts
Principal Investigator:
Steve Braunstein, MD
Sponsor
University of California, San Francisco
Last update posted
Nov 20, 2026
Last verified
Nov, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-21. This information was provided to ClinicalTrials.gov by University of California, San Francisco on 2026-11-20. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.